SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-15-005770
Filing Date
2015-06-25
Accepted
2015-06-25 16:39:51
Documents
3
Period of Report
2015-08-04
Effectiveness Date
2015-06-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2225242zdef14a.htm DEF 14A 580567
2 G147392BGI001.GIF g147392bgi001.gif GRAPHIC 66225
3 G147392BGI002.GIF g147392bgi002.gif GRAPHIC 40958
  Complete submission text file 0001047469-15-005770.txt   729703
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36306 | Film No.: 15952205
SIC: 2834 Pharmaceutical Preparations